Home › Calculator › RPRX Dividend Calculator 2026
RPRX DRIP Calculator & Dividend Yield 2026
1.42% YieldHealthcareRoyalty Pharma plc · NASDAQ
Price: $65.30 · Annual div: $0.9250/share · Frequency: quarterly · Payout ratio: 51% · Ex-div: 2026-11-13
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RPRX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
RPRX Dividend History — Last 26 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-11-13Latest | 2026-12-10 | $0.2350 | — | — |
| 2026-08-14 | 2026-09-10 | $0.2350 | 2.00% | $57.17 |
| 2026-05-15 | 2026-06-10 | $0.2350 | 2.28% | $49.47 |
| 2026-02-20 | 2026-03-10 | $0.2350 | 2.63% | $42.36 |
| 2025-11-14 | 2025-12-10 | $0.2200 | 2.92% | $37.30 |
| 2025-08-15 | 2025-09-10 | $0.2200 | 2.91% | $37.11 |
| 2025-05-16 | 2025-06-10 | $0.2200 | 2.65% | $32.48 |
| 2025-02-21 | 2025-03-10 | $0.2200 | 2.71% | $31.33 |
| 2024-11-15 | 2024-12-10 | $0.2100 | 3.10% | $27.10 |
| 2024-08-16 | 2024-09-13 | $0.2100 | 2.91% | $28.49 |
| 2024-05-16 | 2024-06-14 | $0.2100 | 3.63% | $28.07 |
| 2024-02-15 | 2024-03-15 | $0.2100 | 2.82% | $28.68 |
| 2023-11-16 | 2023-12-15 | $0.2000 | 3.64% | $27.23 |
| 2023-08-17 | 2023-09-15 | $0.2000 | 3.17% | $30.90 |
| 2023-05-18 | 2023-06-15 | $0.2000 | 2.75% | $35.33 |
| 2023-02-15 | 2023-03-15 | $0.2000 | 2.47% | $38.90 |
| 2022-11-17 | 2022-12-15 | $0.1900 | 2.20% | $42.22 |
| 2022-08-18 | 2022-09-15 | $0.1900 | 2.13% | $42.77 |
| 2022-05-19 | 2022-06-15 | $0.1900 | 1.70% | $42.35 |
| 2022-02-17 | 2022-03-15 | $0.1900 | 2.14% | $40.56 |
| 2021-11-18 | 2021-12-15 | $0.1700 | 2.09% | $39.73 |
| 2021-08-19 | 2021-09-15 | $0.1700 | 2.18% | $37.21 |
| 2021-05-19 | 2021-06-15 | $0.1700 | 1.46% | $43.84 |
| 2021-02-18 | 2021-03-15 | $0.1700 | 1.01% | $46.73 |
| 2020-11-19 | 2020-12-15 | $0.1500 | — | — |
| 2020-09-14 | 2020-09-30 | $0.1500 | — | — |
About Royalty Pharma plc (RPRX) — Dividend Analysis 2026
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Similar dividend stocks to RPRX
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RPRX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RPRX position with:
🌍 RPRX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RPRX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1.42% | -1.38% | $142 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1.21% | -1.59% | $121 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1.14% | -1.66% | $114 / yr |
| 🇬🇧 UK ISA | 0% | 1.42% | -1.38% | $142 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1.30% | -1.50% | $130 / yr |
| 🇨🇦 TFSA | 0% | 1.42% | -1.38% | $142 / yr |
| 🇨🇦 CA Taxable | 25% | 1.06% | -1.73% | $107 / yr |
| 🇦🇺 Super (pension) | 15% | 1.21% | -1.59% | $121 / yr |
| 🇦🇺 AU Taxable | 30% | 0.99% | -1.81% | $99 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.05% | -1.75% | $105 / yr |
| 🇫🇷 FR Taxable | 30% | 0.99% | -1.81% | $99 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RPRX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.93/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RPRX Dividend Payment Schedule
RPRX pays quarterly — 4 times per year. Ex-div: 2026-11-13.
📊 RPRX vs Healthcare Benchmarks
How RPRX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RPRX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RPRX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-10-05 | 4,126 | $57.10 | $235.6K | ||
| A-Award | 2026-09-30 | 642 | $58.41 | $37.5K | ||
| Sale | 2026-09-28 | 4,126 | $57.88 | $238.8K | ||
| Sale | 2026-09-22 | 96,073 | $58.51 | $5.62M | ||
| Sale | 2026-09-22 | 3,927 | $58.93 | $231.4K | ||
| Sale | 2026-08-18 | 100,000 | $59.97 | $6.00M | ||
| G-Gift | 2026-08-19 | 16,800 | — | — | ||
| Sale | 2026-08-13 | 9,230 | $58.59 | $540.8K | ||
| Sale | 2026-08-13 | 1,772 | $59.14 | $104.8K | ||
| A-Award | 2026-08-05 | 65,216 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare RPRX with peers: RPRX vs EXEL · RPRX vs FMS · RPRX vs GMAB
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RPRX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Royalty Pharma plc (RPRX) is currently trading at $65.30, trading near its 52-week high. The current dividend yield is 1.42% based on an annual payout of $0.9250 per share.
RPRX (Royalty Pharma plc) — 1.42% Dividend Yield Analysis
Royalty Pharma plc (RPRX) is a healthcare stock currently trading at $65.30 with a dividend yield of 1.42%. It pays an annual dividend of $0.9250 per share. The payout ratio of 51% suggests the dividend is well-covered by earnings. Over the past 5 years, RPRX's dividend has declined at an average rate of 3.1% a year.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest RPRX News
LiveHow investors use the RPRX dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.